SG11202100767XA - Methods for treating neurodegenerative disorders - Google Patents
Methods for treating neurodegenerative disordersInfo
- Publication number
- SG11202100767XA SG11202100767XA SG11202100767XA SG11202100767XA SG11202100767XA SG 11202100767X A SG11202100767X A SG 11202100767XA SG 11202100767X A SG11202100767X A SG 11202100767XA SG 11202100767X A SG11202100767X A SG 11202100767XA SG 11202100767X A SG11202100767X A SG 11202100767XA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- neurodegenerative disorders
- treating neurodegenerative
- treating
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713061P | 2018-08-01 | 2018-08-01 | |
| PCT/US2019/044023 WO2020028290A1 (en) | 2018-08-01 | 2019-07-30 | Methods for treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202100767XA true SG11202100767XA (en) | 2021-02-25 |
Family
ID=67614642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202100767XA SG11202100767XA (en) | 2018-08-01 | 2019-07-30 | Methods for treating neurodegenerative disorders |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210315847A1 (en) |
| EP (1) | EP3829563A1 (en) |
| JP (1) | JP2021533128A (en) |
| KR (1) | KR20210039415A (en) |
| CN (1) | CN112867485A (en) |
| AU (1) | AU2019315853A1 (en) |
| BR (1) | BR112021001739A2 (en) |
| CA (1) | CA3108150A1 (en) |
| CL (1) | CL2021000269A1 (en) |
| EA (1) | EA202190406A1 (en) |
| IL (1) | IL280424A (en) |
| MX (1) | MX2021001287A (en) |
| PH (1) | PH12021550213A1 (en) |
| SG (1) | SG11202100767XA (en) |
| WO (1) | WO2020028290A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022405026A1 (en) * | 2021-12-09 | 2024-06-20 | Alzheon, Inc. | Alz-801 for use in treating alzheimer's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| FI3851447T3 (en) * | 2006-10-12 | 2023-11-15 | Bellus Health Inc | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| US20150359849A1 (en) * | 2013-01-31 | 2015-12-17 | President And Fellows Of Harvard College | Methods of increasing neuronal connectivity and/or treating a neurodegenerative condition |
| US10471029B2 (en) * | 2014-03-21 | 2019-11-12 | Alzheon, Inc. | Methods for treating neurological disorders |
| JP6789579B2 (en) * | 2015-09-10 | 2020-11-25 | アルジオン， インコーポレイテッド | How to Treat Neurodegenerative Disorders in a Specific Patient Population |
-
2019
- 2019-07-30 CA CA3108150A patent/CA3108150A1/en active Pending
- 2019-07-30 SG SG11202100767XA patent/SG11202100767XA/en unknown
- 2019-07-30 US US17/264,477 patent/US20210315847A1/en active Pending
- 2019-07-30 JP JP2021505721A patent/JP2021533128A/en active Pending
- 2019-07-30 AU AU2019315853A patent/AU2019315853A1/en active Pending
- 2019-07-30 BR BR112021001739-9A patent/BR112021001739A2/en unknown
- 2019-07-30 EP EP19752795.5A patent/EP3829563A1/en active Pending
- 2019-07-30 WO PCT/US2019/044023 patent/WO2020028290A1/en unknown
- 2019-07-30 CN CN201980064415.6A patent/CN112867485A/en active Pending
- 2019-07-30 EA EA202190406A patent/EA202190406A1/en unknown
- 2019-07-30 MX MX2021001287A patent/MX2021001287A/en unknown
- 2019-07-30 KR KR1020217005803A patent/KR20210039415A/en unknown
-
2021
- 2021-01-26 IL IL280424A patent/IL280424A/en unknown
- 2021-01-28 PH PH12021550213A patent/PH12021550213A1/en unknown
- 2021-02-01 CL CL2021000269A patent/CL2021000269A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210039415A (en) | 2021-04-09 |
| CL2021000269A1 (en) | 2021-06-18 |
| IL280424A (en) | 2021-03-01 |
| EA202190406A1 (en) | 2021-10-15 |
| EP3829563A1 (en) | 2021-06-09 |
| WO2020028290A1 (en) | 2020-02-06 |
| MX2021001287A (en) | 2021-07-15 |
| JP2021533128A (en) | 2021-12-02 |
| CN112867485A (en) | 2021-05-28 |
| US20210315847A1 (en) | 2021-10-14 |
| BR112021001739A2 (en) | 2021-04-27 |
| PH12021550213A1 (en) | 2021-11-03 |
| CA3108150A1 (en) | 2020-02-06 |
| AU2019315853A1 (en) | 2021-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267082A (en) | Systems and methods for treating neurological disorders | |
| IL262222A (en) | Anti-age antibodies for treating neurodegenerative disorders | |
| IL279308A (en) | Methods for treating hepcidin-mediated disorders | |
| IL273705B (en) | Benzothiazol compounds and methods using the same for treating neurodegenerative disorders | |
| PT3119911T (en) | Methods for treating neurological disorders | |
| SG10201913400QA (en) | Methods for treating lung disorders | |
| IL281052A (en) | Treating liver disorders | |
| EP3454885A4 (en) | Peptides and methods for treating neurodegenerative disorders | |
| HK1256298A1 (en) | Compositions and methods for treating and preventing neurodegenerative disorders | |
| EP3902536A4 (en) | Compositions and methods for treating neurodegenerative disorders | |
| ZA201907238B (en) | Compositions for treating neurodegenerative diseases | |
| EP3313387A4 (en) | Methods and compositions for treating neurodegenerative disorders | |
| SG11202007286TA (en) | Methods for treating mitochondrial disorders | |
| IL280441A (en) | Sulfopropanoic acid derivatives for treating neurodegenerative disorders | |
| GB201803010D0 (en) | Neurodegenerative disorders | |
| GB201701404D0 (en) | Therapies for treating inflammatory disorders | |
| IL289018A (en) | Methods for treating neurodegenerative disorders | |
| IL280424A (en) | Methods for treating neurodegenerative disorders | |
| IL286571A (en) | Compositions and methods for treating neurodegenerative disorders | |
| EP3541474A4 (en) | Methods for treating bone-related disorders | |
| GB201701455D0 (en) | Neurodegenerative disorders | |
| EP3962492A4 (en) | Methods for treating neurodegenerative disorders | |
| PT3420084T (en) | Novel approach for treating inflammatory disorders |